Next Article in Journal
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
Previous Article in Journal
Feature Selection for High-Dimensional and Imbalanced Biomedical Data Based on Robust Correlation Based Redundancy and Binary Grasshopper Optimization Algorithm
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 11
Issue 7
10.3390/genes11070718
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

CircRNA-006258 Sponge-Adsorbs miR-574-5p to Regulate Cell Growth and Milk Synthesis via EVI5L in Goat Mammary Epithelial Cells

by
Meng Zhang
†,
Li Ma
†,
Yuhan Liu
,
Yonglong He
,
Guang Li
,
Xiaopeng An
and
Binyun Cao
*
College of Animal Science and Technology, Northwest A&F University, Yangling 712100, Shanxi, China
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Genes 2020, 11(7), 718; https://doi.org/10.3390/genes11070718
Submission received: 28 May 2020 / Revised: 21 June 2020 / Accepted: 25 June 2020 / Published: 28 June 2020
(This article belongs to the Section Animal Genetics and Genomics)
Browse Figures
Versions Notes

Abstract

The development of the udder and the milk yield are closely related to the number and vitality of mammary epithelial cells. Many previous studies have proved that non-coding RNAs (ncRNAs) are widely involved in mammary gland development and the physiological activities of lactation. Our laboratory previous sequencing data revealed that miR-574-5p was differentially expressed during the colostrum and peak lactation stages, while the molecular mechanism of the regulatory effect of miR-574-5p on goat mammary epithelial cells (GMECs) is unclear. In this study, the targeting relationship was detected between miR-574-5p or ecotropic viral integration site 5-like (EVI5L) and circRNA-006258. The results declared that miR-574-5p induced the down-regulation of EVI5L expression at both the mRNA and protein levels, while circRNA-006258 relieved the inhibitory effect through adsorbing miR-574-5p. EVI5L blocked the G1 phase and promoted the S phase by activating the Rab23/ITGB1/TIAM1/Rac1-TGF-β/Smad pathway in GMECs. By increasing the protein expression of Bcl2 and reducing the protein expression of Bax, EVI5L promoted cell growth and inhibited apoptosis. The activation of the PI3K/AKT–mTOR signaling pathway promoted the production of triacylglycerol (TAG) and β-casein in GMECs. The circRNA–006258/miR-574-5p/EVI5L axis could regulate the cell growth and milk synthesis of GMECs by sponge-adsorbed miR-574-5p. These results would provide scientific evidence for precision animal breeding in the industry of dairy goats.

1. Introduction

MicroRNAs (miRNAs) are a series of small non-coding RNA gene products containing 18–22 nucleotides. Recently, researchers found that miRNAs can bind to 3’ untranslated region (3’ UTR) of target messenger RNAs (mRNAs) and negatively regulate gene expression by transcriptional or translational inhibition [1,2,3]. MiR-574-5p are implicated in the pathophysiology of many tumors, including breast cancer, colorectal cancer and other oncoma [4,5,6]. In addition, miR-574-5p is a very important regulator for cell migration and proliferation [7,8,9]. Based on our laboratory sequencing data, miR-574-5p is differentially expressed in the colostrum and peak lactation periods [10]. MiR-574-5p targets MAP3K9 and reduces the secretion of β-casein and triglycerides through PI3K/AKT–mTOR pathways in goat mammary epithelial cells (GMECs) [11].
Circular RNAs (circRNAs), a kind of endogenous non-coding RNA (ncRNA) with a closed-loop structure, were discovered 40 years ago and are synthesized by a back-splicing event of protein-coding mRNAs that occurs during post-transcriptional processes [12]. At present, many experiments have proved that circRNAs are modulators in numerous malignancies, and the process of cell growth and invasion [13,14,15]. At the present stage, considerable studies have found that circRNAs act as ‘miRNA sponges’ and bind proteins to affect a variety of biological processes [16]. Nevertheless, whether circRNAs participate in the GMEC growth and progression remains to be clarified, and the underlying mechanisms of circRNAs are not expounded syllabify in GMECs.
The Ecotropic viral integration site 5-like (EVI5L) is a member of the EVI5 family. The EVI5 family belongs to a small subfamily of the Tre-2/Bub2/Cdc16 (TBC) domain-containing proteins [17,18]. Comparing mouse with human, the EVI5 family has two prominent domains: a Tre-2/Bub2/Cdc16 (TBC) domain which is related to the proteins that act as GTPase activating proteins (GAPs) for the Rab family GTPases at the N-terminal half, and a coiled-coil region bearing homology to the structural maintenance of chromosomes (SMC) family of ATPases at the C-terminal half [19,20]. Some reports showed that EVI5 might target Rab11 in cytokinesis [19,21], while EVI5L acts on Rab10 and Rab23 in cytosolic [22]. EVI5L takes part in primary cilium formation through binding Rab23 and the high expression of EVI5L significantly reduces primary cilium formation by more than half. Lim’s tests revealed that EVI5L, a putative Rab23 GAP, regulated the signal way-sonic hedgehog (Shh) signaling during mouse growing [23]. For mouse embryos, EVI5L expression was increased in Tgif1, Tgif2-null embryos and in double-null mouse embryo fibroblasts (MEFs) [20]. At present, all of the study of EVI5L is about the primary cilium formation, and reports about other functions of EVI5L are few.
EVI5L was chosen for two reasons: (1) the 3’-UTR of EVI5L has the special nucleotide sequence which attached to the seed sequence of miR-574-5p; (2) EVI5L enigmatically plays roles in cell cycle progression, cytokinesis, and cellular membrane traffic [18]. In our previous work, the ncRNA library was obtained by bioinformatics prediction method. On account of the circRNA-006258 was a significant difference, and we selected it for the future studies. The regulation of circRNA-006258/miR-574-5p/EVI5L was detected by establishing an in vitro culture system of GMECs. Our purpose was to explore a circRNA–miRNA–mRNA network involved in the regulation of mammary epithelial cell growth and milk synthesis, and to reveal its molecular mechanism for the regulation of the lactation performance of dairy goats.

2. Materials and Methods

2.1. Mammary Gland Sample Collection

All the experimental animals in this study were raised in accordance with the announcement NO.5 of the Ministry of Agriculture, and the program of the animal experiment was approved by the animal experiment program application review committee of Northwest A&F University.
In this study, three Guanzhong dairy goats (3 year old, female) at 90 days postpartum during peak lactation were chosen from a local experiment station in Northwest A&F University of China.
The research animals were anesthetized by the intramuscular injection of 150 mg phenobarbital sodium. After 30 min, using a scalpel, incision of 1 cm was cut in the middle of mammary gland, removing about 1 cm3 of mammary gland tissue, before suturing and sterilizing the wound. After 1 week, the surgical line was removed, and all the animals recovered. The mammary tissue samples were placed in phosphate buffer saline (PBS) and transferred immediately to the laboratory. There were 100 μg/mL streptomycin and 100 μg/mL penicillin in the PBS [22,24].

2.2. Cell Culture

Firstly, fresh udder tissues were washed several times until the solution was pellucid and without milk. Secondly, the tissues were cut about 1 mm3 and were washed again with PBS. The smaller tissues were cultured in DME/F-12 medium (Gibco, Waltham, MA, USA) with 10% fetal calf serum (Gibco, Waltham, MA, USA), 5 μg/mL insulin, 100 U/mL penicillin and streptomycin (Gibco, Waltham, MA, USA), 10 ng/mL epidermal growth factor 1 (EGF-1, Gibco, Waltham, MA, USA) at 37 °C in a humidified atmosphere with 5% CO2. After about 1 week, the purified GMECs were received.

2.3. Vector Construction

Some genes were predicted can bind miR-574-5p by using Target Scan (http://www.targetscan.org/). The EVI5L CDS sequence (XM_018050954.1) of the goat were predicted by the NCBI genome website. Firstly, the 3′ UTR fragment of EVI5L was cloned and building the plasmids of EVI5L with psiCHECK2 vector was to obtain WT-EVI5L-psiCHECK2. The fragment was cloned by PCR with the total RNA that was isolated from the GMECs. The specialized pMD™19-T vector (TaKaRa, Beijing, China) was used to get a high-efficiency PCR product and obtained the complete sequence. EVI5L was inserted into the pcDNA3.1 vector (Thermo Fisher, Shanghai, China) so that the restriction enzyme cutting site was Kpn I and Not I. EVI5L (pcDNA3.1) primer information for the vector construction: Forward: CACTAGAGATGGCGAGCCCCACTCTG. Reverse: CTGGGTACCTCAGTTGTCCAGGCCCTGGCT.

2.4. Luciferase Assay

Before the luciferase assay, the psiCHECK-2 vectors (Addgene, Watertown, USA) of the EVI5L and circRNA-006258 were built. The miRNA-574-5p target sites were found from the former studies [11]. Primers of wild psiCHECK-2 vectors were designed and synthesized in the 3’ UTR of EVI5L and circRNA-006258 with special restriction enzyme sites: Xho I and Not I. The primers were used for psiCHECK-2 vectors in Table S1. Then, when the GMECs had a density of 50,000 cells/well in 48-well plates, 0.33 mg psiCHECK-2-EVI5L and psiCHECK-2-circRNA-006258 were cotransfected, respectively, with 10 pmol miRNA-574-5p mimics or inhibitors into cells. After 24 h, renilla and firefly luciferase activities were measured using thermo scientific varioskan flash (Thermo scientific, Waltham, MA, USA) by the Dual-Glo luciferase assay system (Promega, Madison, WI, USA).

2.5. Transfection and RNA Extraction

The cells were cultured in 6-well plates and the density of every well was 80–90%. Using Lipofectamine RNAiMAX Reagent (Invitrogen, Carlsbad, CA, USA) transfected into GMECs with NC, inhNC, miR-574-5p mimics/inhibitors, si-EVI5L (small interfering RNA of EVI5L) (GenePharma, Shanghai, China), si-circ-006258 (GenePharma, Shanghai, China), pcDNA3.1, pcDNA3.1-EVI5L plasmids, after 24 h or 48 h, the cell samples were collected for further experiment. Total RNA was isolated using Trizol reagent (Invitrogen, CA, USA) [25]. RNA concentration and purity were evaluated with Agilent 2100 Bioanalyzer (Agilent Technologies, PaloAlto, CA, USA) and the RNA was stored at −80 °C. Table S2 provides the sequences of EVI5L, circRNA-006258 and miR-574-5p.

2.6. Reverse Transcription and Real-Time PCR

Reverse transcription was conducted according to the introduction of PrimeScript RT reagent Kit with gDNA Eraser (TAKARA, Beijing, China) [26]. SYBR Premix Ex Taq II (TAKARA, Beijing, China) was used to quantify the mRNA standards of disparate genes and the statistics were analyzed with the CFX Connect Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). The validated primers used for RT-qPCR are listed in Table 1. The RT-PCR conditions were: 95 °C for 10 min and then 40 cycles at 94 °C for 15 s, 60 °C for 30 s, followed by 72 °C for 30 s. U6 and β-actin were applied to the internal controls for EVI5L and miR-574-5p mRNA [27]. Each experiment was independently repeated at least three times. The relative expression level was calculated by the N = 2−ΔΔCt method [28]. The analyses were performed in triplicate.

2.7. Western Blot

Cells transfected for 48 h were collected, then the cells were lysed by RIPA (Radio Immunoprecipitation Assay) lysis buffer (Bioteke, Beijing, China) and centrifuged at 4 °C for about 15 min (12,000 ×g). The total protein would go through a series of experiments: 12% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) separated the different protein, and the gels were moved to PVDF (Polyvinylidene fluoride) membranes (Merck Millipore, MA, USA). The PVDF membranes were sealed with 10% skimmed milk powder for 2 h at room temperature. After the membranes were washed three times with Tris-buffered saline plus Tween 20 (TBST), and they were then incubated with the primary antibodies for 4 h, and the mouse or rabbit antibodies for 2 h. All of the main antibodies are shown in Table 2. Subsequently, all the proteins were tested by Quantity One program (Bio-Rad, CA, USA).

2.8. Cell Cycle, Proliferation and Apoptosis Assay

Cell viability and proliferation were tested as previously described with CCK-8 (ZETA™ life, San Francisco, CA, USA) and Edu (Ribobio, Guangzhou, China) [24,29]. The GMECs were cultivated in 96-well plates. After 24, 48, and 72 h transfection, 20 μL CCK8 solution from each well was added to 20 μL CCK8 solution. About 2 h later, using the Epoch microplate reader (Biotek, Winooski, VT, USA), the absorbance at 450 nm was measured. After 24 h transfection, the GMECs were treated with 50 Μm for about 2 h and then DAPI (4’,6-diamidino-2-phenylindole) was added to the mix solution for about 15 min at 37 °C. Then, the cells were washed in PBS three times. A fluorescence microscope was calculated for taking the cell images. The ratio of EdU positive cells (EdUstaining cells/the total of cells) was calculated and each experiment had three independent replicates.
Cell cycle staining Kit (SeaBiotech, Shanghai, China) and the flow cytometer was performed to detect the cell cycle. The cells were harvested and were washed three times with PBS. Then, 75% ethanol in PBS fixed the cell overnight at −20 °C. The apoptosis of the GMECs was tested with the flow cytometry method (FCM) and an Annexin V-FITC PI staining apoptosis assay kit (SeaBiotech, Shanghai, China). There were three replicates per condition for every group.

2.9. Determination of β-Casein and Triglyceride Analysis

After 24 h transfection, the cell-free supernatants and lysates were obtained and were used to test β-casein and the triglyceride analysis. β-casein and the triglyceride analysis of GMECs were carried out with an Enzyme-linked immunosorbent assay (ELISA) kit (Tongwei, Shanghai, China) and a triglycerides quantitative assay kit (Applygen, Beijing, China), respectively [11].

2.10. Statistical Analysis

SPSS 19.0 (Beijing, China) were used to processes all the data present in the experiment. The data could not just be the same and were revealed as the means ± SE (standard error) of the three independent experiments The differences of each group were analyzed using one-way and two-way analysis of variance (ANOVA), then a Bonferroni post-hoc correction for all group comparisons was performed, considered statistically significant at * p < 0.05 and ** p < 0.01.

3. Results

3.1. EVI5L Is One of Target Genes of miR-574-5p in GMECs

The 3’ UTR of EVI5L has the special nucleotide sequence which could be specifically attached to miR-574-5p (Figure 1A,B). From Figure 1C, the groups co-transfected with WT-EVI5L-psiCHECK2 and miR-574-5p mimic significantly attenuated luciferase activities compared with the experiment groups that were co-transfected with WT-EVI5L-psiCHECK2 and negative control (NC). There was no significant change in the co-transcriptional group of miR-574-5p and MUT-EVI5L-psiCHECK2. The results of mRNA detection (Figure 1D) indicated that miR-574-5p mimics apparently down-regulated EVI5L compared to NC; inversely, the EVI5L expression with miR-574-5p inhibitors transparently reduced in contrast with the inhibitor negative control (inhNC). Western blot (Figure 1E) analysis also demonstrated that the miR-574-5p mimics reduced the protein of EVI5L, while the inhibitor-treated group had an opposite performance compared with the inhNC. To sum up, miR-574-5p played a demotivated role for the expression of EVI5L on mRNA and protein levels.

3.2. EVI5L Arrested G0/G1 Phase and Promoted S Phase in GMECs

As shown in Figure 2A,B and Figure S1A,B, for S phase, the number of GMECs in the control group (pcDNA3.1) was more than in the overexpression EVI5L plasmid (pc-EVI5L). However, the groups transfected with miR-574-5p, si-EVI5L and the negative control (NC) indicated that the percentage of cells in the G0/G1 phase of miR-574-5p was less than the NC; as miR-574-5p and si-EVI5L had more cells in S phase than the NC, observably. Therefore, it turned out that EVI5L caused the G0/G1 phase arrest and promoted the S phase in GMECs.
The WB experiment was performed to assess the molecular mechanism of EVI5L on cell cycle regulation in GMECs. Pc-EVI5L increased the protein expression of ITGB1, TIAM1, Rac1 comparing with pcDNA3.1, and compared miR-574-5p or si-EVI5L with the negative control (NC), but the WB result was opposite for ITGB1, TIAM1 and Rac1 (Figure 2C,D). EVI5L also influenced the pathway of TGF-β/Smad (Figure 2E,F). Compared with pcDNA3.1, pc-EVI5L improved the total protein and phosphorylation of Smad3, CDK2, CDK4 and promoted the cyclinE protein, but decreased the protein of cyclinD. Quite the contrary, miR-574-5p and si-EVI5L had different works. In short, EVI5L regulated the cell cycle via the Rab23/ITGB1/TIAM1/Rac1-TGF-β/Smad pathway in GMECs.

3.3. EVI5L Promoted the Growth of GMECs

As shown in Figure 3A and Figure S1C, the overexpression of EVI5L made the quantity of cells better than with pcDNA3.1; comparing with the miR-574-5p+pcDNA3.1-EVI5L group, the number of cells in the pcDNA3.1-EVI5L-treated group was upgraded; while the cells in the group of miR-574-5p mimics decreased. We speculated that EVI5L could promote GMEC proliferation. The trials of NC and si-EVI5L validated this speculation (Figure 3B and Figure S1D). The result of CCK-8 illustrated in Figure 3C,D indicated that EVI5L activated the GMECs and weakened the function of miR-574-5p in the viability of GMECs. Besides, flow cytometry was performed to analyze cell apoptosis (Figure 3E,F and Figure S1E,F). EVI5L had a demotivated effect on GMECs. The effect of si-EVI5L was similar to miR-574-5p, and it also played a negative role in regulating the viability of GMECs. In brief, EVI5L promoted the growth of GMECs and downregulated their apoptosis.
Herein, WB was performed to investigate the effect of EVI5L on Bcl2 and Bax in GMECs. The results showed that the overexpression of EVI5L (pc3.1-EVI5L) increased the expression of Bcl2 but decreased Bax expression, while si-EVI5L had an antipodal impact (Figure 3G,H, Figure S1I,J).

3.4. EVI5L Increased the Milk Synthesis via PI3K/AKT–mTOR Signaling Pathway

After the 24 h transfection of the plasmids in GMECs, EVI5L up-regulated the TAG expression and inhibited the function of miR-574-5p (Figure 4A,B). Figure 4C,D showed that the EVI5L overexpression plasmids (pcDNA3.1-EVI5L) augmented the expression of β-casein in contrast with pcDNA3.1. Si-EVI5L and miR-574-5p. which decreased the expression of β-casein.
The results of the WB assay are shown in Figure 4E,F; EVI5L activated AKT, S6K1, and mTOR. Compared with the pcDNA3.1 group, the AKT, mTOR and S6K1 phosphorylation ratios increased significantly in the EVI5L overexpression vector (pc-EVI5L)-treated group. For miR-574-5p +EVI5L, the AKT and S6K1 phosphorylation ratios were significantly higher than that of miR-574-5p. On the contrary, the si-EVI5L groups decreased AKT, S6K1, and mTOR phosphorylation. MiR-574-5p exerted the same effect as si-EVI5L.

3.5. CircRNA-006258 Promoted EVI5L Expression in GMECs

On the basis of prior work, the target circRNA of miR-574-5p was predicted based on the circRNA library constructed previously. Through referring to this circRNA library and predicting by biological software, we found that there might be a sponge relationship between circRNA-006258 and miR-574-5p (Figure 5A).
To verify this conjecture, we built two types of dual-luciferase reporter vector of circRNA-006258: wild type: WT-circRNA-006258-psiCHECK2 (Figure 5B); and mutant type: MUT-circRNA-006258-psiCHECK2. By measuring the luciferase activity after transfection, we found that the double luciferase activity of the WT-circRNA-006258-psiCHECK2 and miR-574-5p group was significantly lower than that of the WT-circRNA-006258-psiCHECK2 and the negative control (NC) (Figure 5C). There was no significant change for the MUT-circRNA-006258-psiCHECK2 group. It is speculated that circRNA-006258 is capable of adsorbing miR-574-5p as a "sponge". As shown in Figure 5D, the mRNA expression of EVI5L in the si-circRNA-006258 group is notably lower than that of the NC group. The WB assay showed the same results (Figure 5E). It turned out that circRNA-006258 adsorbed miR-574-5p and promoted the expression of EVI5L in GMECs.

3.6. CircRNA-006258 Promoted GMEC Proliferation in GMECs

The cell proliferation was detected by the EdU kit. Figure 6A and Figure S1G indicate that the cell number of the si-circRNA-006258 group was less than that of the NC group. Cells were collected at specific times (24, 48, and 72 h) and tested by CCK-8 to examine the viability of the GMECs. Cell viability decreased significantly for all the time periods (Figure 6B). The cells apoptosis percentage of si-circRNA-006258 increased significantly compared with the NC (Figure 6C and Figure S1H). These results demonstrated that the circRNA-006258 promoted the proliferation of GMECs, enhanced cell viability, and inhibited their apoptosis.

3.7. CircRNA-006258 Promoted Milk Synthesis of GMECs

Figure 6D showed that the triglyceride secretion of GMECs in the si-circRNA-006258 and miR-574-5p group was significantly blocked in contrast with the NC group. Moreover, the β-casein in GMECs after si-circRNA-006258 transfection was significantly reduced compared with the NC group (Figure 6E). Data indicate that circRNA-006258 promoted the synthesis of triglycerides and β-casein in GMECs.

3.8. CircRNA-006258 Regulated Cell Growth and Milk Synthesis

From Figure 7A,B, for the cell cycle of GMECs, we found that si-circRNA-006258 inhibited Rab23/ITGB1/TIAM1/Rac1 protein expression, restrained the percentage of total protein and the phosphorylation of Smad3 and CDK2 in the TGF-β/Smad pathway and depressed the expression of cyclinE. As for regulating the cell growth of GMECs, si-circRNA-006258 inhibited the protein expression of Bcl2 and promoted the expression of the Bax protein (Figure 7C, Figure S1K). Thereby, for milk synthesis in GMECs, si-circRNA-006258 barred the phosphorylation of AKT, mTOR, and S6K1, and inhibited the PI3K/AKT–mTOR pathway (Figure 7D).

4. Discussion

Researchers found that the TGF-β/SMAD pathway could influence cell growth and regulate the cell cycle to transform G1 into S phase [30]. Complexes of cyclin-dependent kinases (CDKs) and cyclins the regulated cell cycle. CDK4/CDK6-cyclin D and CDK2-cyclin E separately altered the G1 and S phase of cells [31]. In our experiment, flow cytometry confirmed that EVI5L promoted S phase in GMECs, and the results of the WB assay for the protein of the cell cycle showed that EVI5L promoted the expression of CDK4, CDK2, cyclinD1 but inhibited cyclinE protein in GMECs. This is consistent with the report of Clurman B.E. [32]. Cells stopped at the G1 phase will go into G0 phase, which is known as the static condition: no growth, no fission and no migration. The cells in G0 phase will exaggerate the limit point and quickly return to the cell cycle and proliferation when they are stimulated by external signals such as serum and growth factors [33]. The hypophosphorylated and dephosphorylated of pRb appear in the G0 phase, while the Phosphorylation prevents cells from re-entering the cell cycle and phosphorylated pRb mediates G0/G1 transformation [34]. Beyond that, the Myc pathway takes the main role for cell cycle. Therefore, the effect of EVI5L on the Myc pathway in GEMCs is supposed to be explored and illuminated in the next stage.
Rab23 promotes hepatocellular carcinoma cell migration via the Rac1/TGF-β signaling pathway and promotes squamous cell carcinoma cell migration and invasion by regulating the integrin β1/Tiam1/Rac1 pathway [35]. Curcumin could inhibit SDF-1α-induced invasion through Rac1/PI3K/Akt signaling complexes in human esophageal carcinoma cells [35,36,37,38]. Hence, we speculated that these pathways might regulate the biological processes in GMECs. Therefore, we measured the related protein expression by WB. The function of EVI5L was brought into effect by Rab23/ITGB1/TIAM1/Rac1 in GMECs. Additionally, EVI5L affected the growth of the GMECs via Rac1-TGF-β/Smad and Bax, Bcl2. The activation of the PI3K/AKT–mTOR pathway by EVI5L accelerated the milk synthesis of the GMECs.
More and more studies have proved that non-coding RNA (ncRNAs) molecules are widely involved in udder development and the physiological activities of lactation. The competitive endogenous RNA (ceRNA) hypothesis is a new model for post transcriptional gene regulation. According to the hypothesis, the expressions of designated miRNAs are reduced by ceRNA [39]. Nowadays, a lot of evidence has attested that the form circRNA–miRNA–mRNA is important to explore the pathogenesis of tumors and other diseases. On the strength of this research, their targeted drugs are expected to be found. Building the circRNA–miRNA–mRNA template, various biological processes were better elucidated. Xiaotong Su et al. reported that circ-0070269/miR-182/NPTX1 played a significance role in hepatocellular carcinoma (HCC), and that this axis could serve as a potential therapeutic target [40]. Another research revealed that circ-016910 bound miR-574-5p to regulate cell physiology and milk synthesis via MAPK and PI3K/AKT–mTOR pathways in GMECs [11]. The reporters of the circRNA–miRNA–mRNA net are fewer in goat lactation performance. We found that circRNA-006258 directly bound miR-574-5p by the dual-luciferase reporter system. CircRNA-006258 relieved the inhibitory effect of miR-574-5p on EVI5L through sponging miR-574-5p. We established the network of circRNA-006258-miR-574-5p-EVI5L to fill the gap.
In conclusion, based on the result of preliminary laboratory research: miR-574-5p is differentially expressed in the colostrum and the peak lactation periods the target gene of miR-574-5p and ncRNA database were established by the laboratory, and miR-574-5p was selected as the research object. The targeting relationship between miR-574-5p and EVI5L was studied as well as circRNA-006258, to elucidate the molecular regulation mechanism of mammary epithelial cells in lactating goats. This study may contribute to determine the better regulation molecular mechanism of lactation performance in dairy goats.

5. Conclusions

In brief, our data indicated that circ-006258 was a sponge for miR-574-5p to regulate the growth and milk synthesis through EVI5L in the lactation period of GMECs. We founded the circRNA-006258/miR-574-5p/EVI5L axis and elucidated the function and the regulatory mechanism of this axis in the lactation period of GMECs (Figure 8).

Supplementary Materials

The following are available online at https://www.mdpi.com/2073-4425/11/7/718/s1, Figure S1: EVI5L and circ-006258 promoted GMEC proliferation in GMECs, Table S1: The validated primers used for psiCHECK-2 vectors, Table S2: EVI5L, circRNA-006258 and miR-574-5p sequences.

Author Contributions

Conceptualization, M.Z. and L.M.; methodology, Y.H.; software, Y.L.; validation, Y.L., B.C. and X.A.; formal analysis, G.L.; investigation, Y.L., M.Z. and L.M.; resources, B.C.; writing—original draft preparation, M.Z. and L.M.; writing—review and editing, B.C. and G.L.; visualization, G.L.; supervision, X.A.; project administration, X.A.; funding acquisition, B.C., M.Z. and L.M. contributed equally to this work. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the Shaanxi Science, Technology Innovation Project Plan (2017ZDXM-NY-081 and 2018ZDCXL-NY-01-04) and Shaanxi key research and development program (2020ZDLNY02-01 and 2020ZDLNY02-02).

Acknowledgments

This research is supported by Natural Science Foundation of Shaanxi Province (2020JQ-868).

Conflicts of Interest

For this article, there is no conflict of interest regarding for all authors to publish.

References

  1. Ambros, V.; Bartel, B.; Bartel, D.P.; Burge, C.B.; Carrington, J.C.; Chen, X.; Dreyfuss, G.; Eddy, S.R.; Griffiths-Jones, S.; Marshall, M.; et al. A uniform system for microRNA annotation. RNA 2003, 9, 277–279. [Google Scholar] [CrossRef] [PubMed]
  2. E Pasquinelli, A.; Hunter, S.; Bracht, J. MicroRNAs: A developing story. Curr. Opin. Genet. Dev. 2005, 15, 200–205. [Google Scholar] [CrossRef] [PubMed]
  3. Chandra, S.; Vimal, D.; Sharma, D.; Rai, V.; Gupta, S.C.; Chowdhuri, D.K. Role of miRNAs in development and disease: Lessons learnt from small organisms. Life Sci. 2017, 185, 8–14. [Google Scholar] [CrossRef]
  4. Chen, P.; Zhong, J.; Ye, J.; He, Y.; Liang, Z.; Cheng, Y.; Zheng, J.; Chen, H.; Chen, C. miR-324-5p protects against oxidative stress-induced endothelial progenitor cell injury by targeting Mtfr1. J. Cell. Physiol. 2019, 234, 22082–22092. [Google Scholar] [CrossRef] [PubMed]
  5. Han, Z.; Zhu, Y.; Cui, Z.; Guo, P.; Wei, A.; Meng, Q. MicroRNA Let-7f-1-3p attenuates smoke-induced apoptosis in bronchial and alveolar epithelial cells in vitro by targeting FOXO1. Eur. J. Pharmacol. 2019, 862, 172531. [Google Scholar] [CrossRef]
  6. Xiaopeng, A.; Yue, Z.; Jidan, L.; Xingna, M.; Zhaoyu, G.; Cao, B. NTS Targeted By miR-182 Modulates the Apoptosis of Goat Endometrial Epithelial Cells; Acta Veterinaria: Belgrade, Serbia, 2019; Volume 69, pp. 340–347. [Google Scholar] [CrossRef]
  7. Li, C.; Tan, F.; Pei, Q.; Zhou, Z.; Zhou, Y.; Zhang, L.; Wang, D.; Pei, H. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis. Cell Prolif. 2019, 52, e12632. [Google Scholar] [CrossRef]
  8. Zhang, Z.; Li, X.; Xiao, Q.; Wang, Z. MiR-574-5p mediates the cell cycle and apoptosis in thyroid cancer cells via Wnt/beta-catenin signaling by repressing the expression of Quaking proteins. Oncol. Lett. 2018, 15, 5841–5848. [Google Scholar]
  9. Wang, X.; Lu, X.; Geng, Z.; Yang, G.; Shi, Y. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/-Catenin Signaling. J. Cell. Biochem. 2017, 118, 4745–4752. [Google Scholar] [CrossRef]
  10. Hou, J.; An, X.; Song, Y.; Cao, B.; Yang, H.; Zhang, Z.; Shen, W.; Li, Y. Detection and comparison of microRNAs in the caprine mammary gland tissues of colostrum and common milk stages. BMC Genet. 2017, 18, 38. [Google Scholar] [CrossRef]
  11. Liu, Y.; Hou, J.; Zhang, M.; Seleh-Zo, E.; Wang, J.; Cao, B.; An, X. circ-016910 sponges miR-574-5p to regulate cell physiology and milk synthesis via MAPK and PI3K/AKT–mTOR pathways in GMECs. J. Cell. Physiol. 2019, 235, 4198–4216. [Google Scholar] [CrossRef]
  12. Wang, Y.; Wang, L.; Wang, W.; Guo, X. Overexpression of circular RNA hsa_circ_0001038 promotes cervical cancer cell progression by acting as a ceRNA for miR-337-3p to regulate cyclin-M3 and metastasis-associated in colon cancer 1 expression. Gene 2020, 733, 144273. [Google Scholar] [CrossRef] [PubMed]
  13. Xiang, S.; Li, Z.; Weng, X. Changed cellular functions and aberrantly expressed miRNAs and circRNAs in bone marrow stem cells in osteonecrosis of the femoral head. Int. J. Mol. Med. 2020, 45, 805–815. [Google Scholar] [CrossRef] [PubMed]
  14. Sheng, R.; Li, X.; Wang, Z.; Wang, X. Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer. Cancer Lett. 2020, 473, 139–147. [Google Scholar] [CrossRef] [PubMed]
  15. Ma, H.-B.; Yao, Y.-N.; Yu, J.-J.; Chen, X.-X.; Li, H. Extensive profiling of circular RNAs and the potential regulatory role of circRNA-000284 in cell proliferation and invasion of cervical cancer via sponging miR-506. Am. J. Transl. Res. 2018, 10, 592–604. [Google Scholar]
  16. Curry-Hyde, A.; Ueberham, U.; Arendt, T.; Janitz, M. Neural circular transcriptomes across mammalian species. Genomics 2020, 112, 1162–1166. [Google Scholar] [CrossRef]
  17. Frasa, M.A.; Koessmeier, K.T.; Ahmadian, M.R.; Braga, V.M. Illuminating the functional and structural repertoire of human TBC/RABGAPs. Nat. Rev. Mol. Cell Biol. 2012, 13, 67. [Google Scholar] [CrossRef]
  18. Lim, Y.S.; Tang, B.L. The Evi5 family in cellular physiology and pathology. FEBS Lett. 2013, 587, 1703–1710. [Google Scholar] [CrossRef]
  19. Dabbeekeh, J.T.S.; Faitar, S.L.; Dufresne, C.P.; Cowell, J.K. The EVI5 TBC domain provides the GTPase-activating protein motif for RAB11. Oncogene 2006, 26, 2804–2808. [Google Scholar] [CrossRef]
  20. Anderson, A.E.; Taniguchi, K.; Hao, Y.; Melhuish, T.A.; Shah, A.; Turner, S.D.; Sutherland, A.E.; Wotton, D. Tgif1 and Tgif2 Repress Expression of the RabGAP Evi5l. Mol. Cell. Boil. 2016, 37, e00527-16. [Google Scholar] [CrossRef]
  21. Westlake, C.J.; Junutula, J.R.; Simon, G.C.; Pilli, M.; Prekeris, R.; Scheller, R.H.; Jackson, P.K.; Eldridge, A.G. Identification of Rab11 as a small GTPase binding protein for the Evi5 oncogene. Proc. Natl. Acad. Sci. USA 2007, 104, 1236–1241. [Google Scholar] [CrossRef]
  22. Shi, H.; Luo, J.; Zhu, J.; Li, J.; Sun, Y.; Lin, X.; Zhang, L.; Yao, D.; Shi, H. PPAR gamma Regulates Genes Involved in Triacylglycerol Synthesis and Secretion in Mammary Gland Epithelial Cells of Dairy Goats. PPAR Res. 2013, 2013, 1–10. [Google Scholar] [CrossRef] [PubMed]
  23. Lim, Y.S.; Tang, B.L. A role for Rab23 in the trafficking of Kif17 to the primary cilium. J. Cell Sci. 2015, 128, 2996–3008. [Google Scholar] [CrossRef]
  24. Ma, L.; Qiu, H.; Chen, Z.; Li, L.; Zeng, Y.; Luo, J.; Gou, D. miR-25 modulates triacylglycerol and lipid accumulation in goat mammary epithelial cells by repressing PGC-1beta. J. Anim. Sci. Biotechnol. 2018, 9, 48. [Google Scholar] [CrossRef] [PubMed]
  25. Chen, Z.; Shi, H.; Sun, S.; Luo, J.; Zhang, W.; Hou, Y.; Loor, J. MiR-183 regulates milk fat metabolism via MST1 in goat mammary epithelial cells. Gene 2018, 646, 12–19. [Google Scholar] [CrossRef] [PubMed]
  26. Liu, X.; Zhang, L.; Liu, Y.; Cui, J.; Che, S.; An, X.; Song, Y.; Cao, B. Circ-8073 regulates CEP55 by sponging miR-449a to promote caprine endometrial epithelial cells proliferation via the PI3K/AKT/mTOR pathway. Biochim. Biophys. Acta (BBA) Bioenerg. 2018, 1865, 1130–1147. [Google Scholar] [CrossRef]
  27. Lin, X.; Luo, J.; Zhang, L.; Wang, W.; Shi, H.; Zhu, J. MiR-27a suppresses triglyceride accumulation and affects gene mRNA expression associated with fat metabolism in dairy goat mammary gland epithelial cells. Gene 2013, 521, 15–23. [Google Scholar] [CrossRef]
  28. Han, P.; Guerrero-Netro, H.; Estienne, A.; Cao, B.; Price, C.A. Regulation and action of early growth response 1 in bovine granulosa cells. Reproduction 2017, 154, 547–557. [Google Scholar] [CrossRef]
  29. Li, H.; Yang, J.; Wei, X.; Song, C.; Dong, D.; Huang, Y.; Lan, X.; Plath, M.; Lei, C.; Ma, Y.; et al. CircFUT10 reduces proliferation and facilitates differentiation of myoblasts by sponging miR-133a. J. Cell. Physiol. 2018, 233, 4643–4651. [Google Scholar] [CrossRef]
  30. Jahangirimoez, M.; Medlej, A.; Tavallaie, M.; Soltani, B. Hsa-miR-587 Regulates TGFβ/SMAD Signaling and Promotes Cell Cycle Progression. Pathways 2019, 22, 158–164. [Google Scholar]
  31. Moiseeva, T.N.; Qian, C.; Sugitani, N.; Osmanbeyoglu, H.U.; Bakkenist, C.J. WEE1 kinase inhibitor AZD1775 induces CDK1 kinase-dependent origin firing in unperturbed G1- and S-phase cells. Proc. Natl. Acad. Sci. USA 2019, 116, 23891–23893. [Google Scholar] [CrossRef]
  32. E Clurman, B.; Sheaff, R.J.; Thress, K.; Groudine, M.; Roberts, J.M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genome Res. 1996, 10, 1979–1990. [Google Scholar] [CrossRef] [PubMed]
  33. Canhoto, A.J.; Chestukhin, A.; Litovchick, L.; DeCaprio, J.A. Phosphorylation of the retinoblastoma-related protein p130 in growth-arrested cells. Oncogene 2000, 19, 5116–5122. [Google Scholar] [CrossRef]
  34. Sage, J.; Miller, A.L.; Perez-Mancera, P.A.; Wysocki, J.M.; Jacks, T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 2003, 424, 223–228. [Google Scholar] [CrossRef] [PubMed]
  35. Jian, Q.; Miao, Y.; Tang, L.; Huang, M.; Yang, Y.; Ba, W.; Liu, Y.; Chi, S.; Li, C. Rab23 promotes squamous cell carcinoma cell migration and invasion via integrin β1/Rac1 pathway. Oncotarget 2016, 7, 5342–5352. [Google Scholar] [CrossRef] [PubMed]
  36. Shen, T.; Huang, S. The role of Cdc25A in the regulation of cell proliferation and apoptosis. Anti-Cancer Agents Med. Chem. 2012, 12, 631–639. [Google Scholar] [CrossRef]
  37. Lin, M.L.; Lu, Y.C.; Chen, H.Y.; Lee, C.C.; Chung, J.G.; Chen, S.S. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells. Mol. Carcinog. 2014, 53, 360–379. [Google Scholar] [CrossRef] [PubMed]
  38. Zhang, L.; Zhang, B.; You, W.; Li, P.; Kuang, Y. Rab23 Promotes Hepatocellular Carcinoma Cell Migration Via Rac1/TGF-β Signaling. Pathol. Oncol. Res. 2018, 26, 301–306. [Google Scholar] [CrossRef] [PubMed]
  39. Wang, G.; Guo, X.; Cheng, L.; Chu, P.; Chen, M.; Chen, Y.; Chang, C. An integrated analysis of the circRNA–miRNA–mRNA network reveals novel insights into potential mechanisms of cell proliferation during liver regeneration. Artif. Cells Nanomed. Biotechnol. 2019, 47, 3873–3884. [Google Scholar] [CrossRef] [PubMed]
  40. Su, X.; Su, J.; He, H.; Zhan, Y.; Liu, H. Hsa_circ_0070269 inhibits hepatocellular carcinoma progression through modulating miR-182/NPTX1 axis. Biomed. Pharmacother. 2019, 120, 109497. [Google Scholar] [CrossRef]
Genes 11 00718 g001
Figure 1. MiR-574-5p-targeted and down-regulated EVI5L. (A) EVI5L presents a complementary sequence (GCS), 3′ untranslated region (3′ UTR), binding the seed sequence of miR-574-5p. (B,C) Contribution vector to test the luciferase expression and the result of the luciferase assay. (D) The analysis result about the mRNA expression of EVI5L by RT-qPCR. (E) Western blot analysis of EVI5L expression after 48 h transfection with miR-574-5p mimics, inhibitors, NC and inhNC in goat mammary epithelial cells (GMECs). WT-EVI5L-WT, WT-EVI5L-psiCHECK2; EVI5L-mut, MUT-EVI5L-psiCHECK2; NC: negative control; inhNC: inhibitor negative control. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Figure 1. MiR-574-5p-targeted and down-regulated EVI5L. (A) EVI5L presents a complementary sequence (GCS), 3′ untranslated region (3′ UTR), binding the seed sequence of miR-574-5p. (B,C) Contribution vector to test the luciferase expression and the result of the luciferase assay. (D) The analysis result about the mRNA expression of EVI5L by RT-qPCR. (E) Western blot analysis of EVI5L expression after 48 h transfection with miR-574-5p mimics, inhibitors, NC and inhNC in goat mammary epithelial cells (GMECs). WT-EVI5L-WT, WT-EVI5L-psiCHECK2; EVI5L-mut, MUT-EVI5L-psiCHECK2; NC: negative control; inhNC: inhibitor negative control. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Genes 11 00718 g001
Genes 11 00718 g002
Figure 2. EVI5L caused the G0/G1 phase arrest and promoted the S phase in the GMECs. (A) Pc-EVI5L and pcDNA3.1 were transfected in GMECs and the cells were cultured for about 24 h before collection, then the cell cycle was examined by FCM. (B) FCM analyzed the cell cycle of the GMECs transfected with miR-574-5p, si-EVI5L, and NC. (C,D) EVI5L affected the protein expression of the Rab23/ITGB1/TIAM1/Rac1 pathway in the WB assay. (E,F) Western blot analysis used to assess the effect of EVI5L on the TGF-β/Smad pathway in GMECs. FCM: flow cytometry analysis; pc-EVI5L, overexpression EVI5L plasmid; pcDNA3.1: control group; NC: negative control; si-EVI5L: small interfering RNA of EVI5L; EVI5L +miR-574-5p: pcDNA3.1-EVI5L+miR-574-5p. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Figure 2. EVI5L caused the G0/G1 phase arrest and promoted the S phase in the GMECs. (A) Pc-EVI5L and pcDNA3.1 were transfected in GMECs and the cells were cultured for about 24 h before collection, then the cell cycle was examined by FCM. (B) FCM analyzed the cell cycle of the GMECs transfected with miR-574-5p, si-EVI5L, and NC. (C,D) EVI5L affected the protein expression of the Rab23/ITGB1/TIAM1/Rac1 pathway in the WB assay. (E,F) Western blot analysis used to assess the effect of EVI5L on the TGF-β/Smad pathway in GMECs. FCM: flow cytometry analysis; pc-EVI5L, overexpression EVI5L plasmid; pcDNA3.1: control group; NC: negative control; si-EVI5L: small interfering RNA of EVI5L; EVI5L +miR-574-5p: pcDNA3.1-EVI5L+miR-574-5p. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Genes 11 00718 g002
Genes 11 00718 g003
Figure 3. EVI5L promoted the growth of GMECs. (A,B) EdU was used to analyze cell proliferation when the GMECs were cultured for about 24 h after transfection.(C,D) Using CCK-8 to test the activity of GMECs which were cultured for 24, 48 and 72 h after transfection. (E,F) Flow cytometry was performed to analyze cell apoptosis after transfecting for about 24 h. (G,H) WB assay was conducted to investigate the protein expression of Bcl2 and Bax in the GMECs. Pc-EVI5L: overexpression EVI5L plasmid; pcDNA3.1: control group; NC: negative control; si-EVI5L: small interfering RNA; miR-574-5p+EVI5L: miR-574-5p+pcDNA3.1-EVI5L. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Figure 3. EVI5L promoted the growth of GMECs. (A,B) EdU was used to analyze cell proliferation when the GMECs were cultured for about 24 h after transfection.(C,D) Using CCK-8 to test the activity of GMECs which were cultured for 24, 48 and 72 h after transfection. (E,F) Flow cytometry was performed to analyze cell apoptosis after transfecting for about 24 h. (G,H) WB assay was conducted to investigate the protein expression of Bcl2 and Bax in the GMECs. Pc-EVI5L: overexpression EVI5L plasmid; pcDNA3.1: control group; NC: negative control; si-EVI5L: small interfering RNA; miR-574-5p+EVI5L: miR-574-5p+pcDNA3.1-EVI5L. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Genes 11 00718 g003
Genes 11 00718 g004
Figure 4. EVI5L increased the milk synthesis in GMECs via the PI3K/AKT–mTOR pathway. (A,B) The secretion of triglycerides in GMECs was measured with a detection kit. (C,D) The expression of β-casein in the cell-free supernatants by enzyme-linked immunosorbent assay kit. (E,F) WB assay was performed to detect the protein expression of the PI3K/AKT–mTOR pathway in GMECs. Pc-EVI5L: overexpression EVI5L plasmid; pcDNA3.1: control group; NC: negative control; si-EVI5L: small interfering RNA; miR-574-5p+EVI5L: miR-574-5p+pcDNA3.1-EVI5L. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Figure 4. EVI5L increased the milk synthesis in GMECs via the PI3K/AKT–mTOR pathway. (A,B) The secretion of triglycerides in GMECs was measured with a detection kit. (C,D) The expression of β-casein in the cell-free supernatants by enzyme-linked immunosorbent assay kit. (E,F) WB assay was performed to detect the protein expression of the PI3K/AKT–mTOR pathway in GMECs. Pc-EVI5L: overexpression EVI5L plasmid; pcDNA3.1: control group; NC: negative control; si-EVI5L: small interfering RNA; miR-574-5p+EVI5L: miR-574-5p+pcDNA3.1-EVI5L. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Genes 11 00718 g004
Genes 11 00718 g005
Figure 5. CircRNA-006258 promoted the EVI5L expression in GMECs. (A) circRNA-006258 existed complementary sequence (GCS) binding the seed sequence of miR-574-5p. (B,C) Contribution vector used to test the luciferase expression and the result of luciferase assay. (D) The analysis result concerning the mRNA expression of EVI5L by RT-qPCR. (E) Western blot analysis of EVI5L expression after 48 h transfection with circRNA-006258 and NC in GMECs. Dual-luciferase reporter vector of circRNA-006258: wild type: WT-circRNA-006258-psiCHECK2; mutant type: MUT-circRNA-006258-psiCHECK2; NC: negative control; si-circRNA-006258: small interfering RNA. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Figure 5. CircRNA-006258 promoted the EVI5L expression in GMECs. (A) circRNA-006258 existed complementary sequence (GCS) binding the seed sequence of miR-574-5p. (B,C) Contribution vector used to test the luciferase expression and the result of luciferase assay. (D) The analysis result concerning the mRNA expression of EVI5L by RT-qPCR. (E) Western blot analysis of EVI5L expression after 48 h transfection with circRNA-006258 and NC in GMECs. Dual-luciferase reporter vector of circRNA-006258: wild type: WT-circRNA-006258-psiCHECK2; mutant type: MUT-circRNA-006258-psiCHECK2; NC: negative control; si-circRNA-006258: small interfering RNA. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Genes 11 00718 g005
Genes 11 00718 g006
Figure 6. CircRNA-006258 promoted GMEC growth. (A) EdU was used to analyze the cell proliferation when the GMECs were cultured for about 24 h after transfection. (B) Cell viability of the GMECs was determined by CCK-8 when the cells were cultured for 24, 48, and 72 h after transfection. (C) Flow cytometry was performed to analyze cell apoptosis after transfecting for about 24 h. (D) The secretion of triglycerides in the GMECs was measured with a detection kit. (E) The expression of β-casein in the cell-free supernatants by enzyme-linked immunosorbent assay kit. NC: negative control; si-circRNA-006258: small interfering RNA. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Figure 6. CircRNA-006258 promoted GMEC growth. (A) EdU was used to analyze the cell proliferation when the GMECs were cultured for about 24 h after transfection. (B) Cell viability of the GMECs was determined by CCK-8 when the cells were cultured for 24, 48, and 72 h after transfection. (C) Flow cytometry was performed to analyze cell apoptosis after transfecting for about 24 h. (D) The secretion of triglycerides in the GMECs was measured with a detection kit. (E) The expression of β-casein in the cell-free supernatants by enzyme-linked immunosorbent assay kit. NC: negative control; si-circRNA-006258: small interfering RNA. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Genes 11 00718 g006
Genes 11 00718 g007
Figure 7. CircRNA-006258 promoted the milk synthesis of GMECs. (A) CircRNA-006258 influenced the protein expression of the Rab23/ITGB1/TIAM1/Rac1 pathway by WB. (B) Western blot analysis assessed the activation of circRNA-006258 on the TGF-β/Smad pathway in GMECs. (C) WB assay was conducted to investigate the protein expression of Bcl2 and Bax in the GMECs. (D) Investigating the effect of circRNA-006258 on the protein expression of the PI3K/AKT–mTOR pathway by WB assay in the GMECs. NC: negative control; si-circRNA-006258: small interfering RNA. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Figure 7. CircRNA-006258 promoted the milk synthesis of GMECs. (A) CircRNA-006258 influenced the protein expression of the Rab23/ITGB1/TIAM1/Rac1 pathway by WB. (B) Western blot analysis assessed the activation of circRNA-006258 on the TGF-β/Smad pathway in GMECs. (C) WB assay was conducted to investigate the protein expression of Bcl2 and Bax in the GMECs. (D) Investigating the effect of circRNA-006258 on the protein expression of the PI3K/AKT–mTOR pathway by WB assay in the GMECs. NC: negative control; si-circRNA-006258: small interfering RNA. ** means significant difference (p < 0.01), * means significant difference (p < 0.05).
Genes 11 00718 g007
Genes 11 00718 g008
Figure 8. circ-006258/miR-574-5p/EVI5L regulates cell growth and the milk synthesis in GMECs.
Figure 8. circ-006258/miR-574-5p/EVI5L regulates cell growth and the milk synthesis in GMECs.
Genes 11 00718 g008
Table 1. Primer information for RT-qPCR.
Table 1. Primer information for RT-qPCR.
GeneGenBank Accession No. Primer Sequences (5’→3’)
miR-574-5p FORWARD: CGGTATGAGTGTGTGTGTGTGAG
REVERSE: ATCCAGTGCAGGGTCCGAGG
RT PRIMER: GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCACACA
U6 FORWARD: CTCGCTTCGGCAGCACA
REVERSE: AACGCTTCACGAATTTGCGT
EVI5LXM_018050954.1FORWARD:TGTGTTCGTGCGGCTGATGC
REVERSE:AGGTGGTGAGGAAGAGTGTGAGG
circRNA-006258/FORWARD:AGCGGCATCTCCACCATCTG
REVERSE:GAAACACTTGGCTGGGCTGG
β-actin XM_018039831.1FORWARD: GATCTGGCACCACACCTTCT
REVERSE: GGGTCATCTTCTCACGGTTG
Table 2. All of the main antibodies of Western blot (WB).
Table 2. All of the main antibodies of Western blot (WB).
NameManufacturerProduct Number
β-actinBeyotime, Shanghai, ChinaAA128
EVI5Labcam, Cambridge, U.K.ab243722
Rab 23ABclonal, Wuhan, ChinaA7979
ITGB 1Sangon Biotech, Shanghai, ChinaD120869
TIAM 1ABclonal, Wuhan, ChinaA10252
Rac 1ABclonal, Wuhan, ChinaA7720
Smad 3ABclonal, Wuhan, ChinaA11388
p-Smad 3ABclonal, Wuhan, ChinaAo0554
CDK 4Sangon Biotech, Shanghai, ChinaD120396
p-CDK 4ABclonal, Wuhan, ChinaAp0593
Cyclin D1ABclonal, Wuhan, ChinaA11310
CDK 2Sangon Biotech, Shanghai, ChinaD120395
p-CDK 2Sangon Biotech, Shanghai, ChinaD155352
Cyclin E1ABclonal, Wuhan, ChinaA14225
AKTCell Signaling, America#9272
p-AKTCell Signaling, America#9271
mTORAbway, Beijing, ChinaCY5306
p-mTORBoster, Wnhan, China BM4840
Bcl 2Abway, Beijing, ChinaCY6717
BAXAbway, Beijing, ChinaCY5059
S6K1BBI, Shanghai, ChinaD199437
p-S6K1BBI, Shanghai, ChinaD151520

Share and Cite

MDPI and ACS Style

Zhang, M.; Ma, L.; Liu, Y.; He, Y.; Li, G.; An, X.; Cao, B. CircRNA-006258 Sponge-Adsorbs miR-574-5p to Regulate Cell Growth and Milk Synthesis via EVI5L in Goat Mammary Epithelial Cells. Genes 2020, 11, 718. https://doi.org/10.3390/genes11070718

AMA Style

Zhang M, Ma L, Liu Y, He Y, Li G, An X, Cao B. CircRNA-006258 Sponge-Adsorbs miR-574-5p to Regulate Cell Growth and Milk Synthesis via EVI5L in Goat Mammary Epithelial Cells. Genes. 2020; 11(7):718. https://doi.org/10.3390/genes11070718

Chicago/Turabian Style

Zhang, Meng, Li Ma, Yuhan Liu, Yonglong He, Guang Li, Xiaopeng An, and Binyun Cao. 2020. "CircRNA-006258 Sponge-Adsorbs miR-574-5p to Regulate Cell Growth and Milk Synthesis via EVI5L in Goat Mammary Epithelial Cells" Genes 11, no. 7: 718. https://doi.org/10.3390/genes11070718

APA Style

Zhang, M., Ma, L., Liu, Y., He, Y., Li, G., An, X., & Cao, B. (2020). CircRNA-006258 Sponge-Adsorbs miR-574-5p to Regulate Cell Growth and Milk Synthesis via EVI5L in Goat Mammary Epithelial Cells. Genes, 11(7), 718. https://doi.org/10.3390/genes11070718

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop